Schedule

* Disclaimer: All are subject to change

DAY 1: Conference (7th December 2022)

Time

Activities

0800

Registration

0830

Welcome & Opening Address

0845

Plenary Session 1
Cancer Immunotherapy in 2022 – End of the Beginning
Associate Professor Dr. Toh Han Chong
(National Cancer Centre, Singapore)
Chairperson: Associate Professor Dr. Rozita Abdul Malik (University of Malaya, Malaysia)

0930

Forum 1
Cancer Drug Access
Moderator: Associate Professor Dr. Bahariah Khalid
(Universiti Putra Malaysia)
Panelists:
– Professor Dr. How Soon Hin (International Islamic University Malaysia)
– Dr. Murallitharan Munisamy (National Cancer Society Malaysia)
Dr. Yolanda Augustin (St George’s University of London, UK)
Professor Datin Dr. Rozi Mahmud (Universiti Putra Malaysia)
Professor Dato’ Dr. Fuad Ismail (Universiti Kebangsaan Malaysia)
Dr. Azrul Mohd Khalib (Galen Centre for Health and Social Policy)
Mr. Jegatheswaran Panderengen (Novartis Corporation, Malaysia)

1030

Morning Coffee/Tea Break
Poster Viewing & Judging Session 1

1100

Sponsor Talk 1
Mr. Jegatheswaran Panderengen
(Novartis Corporation, Malaysia)

1125

Invited Talk 1
ATLAS Project and the Future of International Collaborative Clinical Research in Asia
Dr. Mitsumi Terada
(National Cancer Center, Japan)
Chairperson: Dr. Yolanda Augustin (St George’s University of London, United Kingdom)

1145

Invited Talk 2
Developing Affordable Cancer Therapeutics in Low and Middle Income Countries
Dr. Yolanda Augustin
(St George’s University of London, United Kingdom)
Chairperson: Dr. Mastura Md Yusof (Pantai Hospital Kuala Lumpur, Malaysia)

1205

Invited Talk 3
Triple Negative Breast Cancer; Tumour Biology and Optimisation of Clinical Outcome
Dr. Mastura Md Yusof
(Pantai Hospital Kuala Lumpur, Malaysia)
Chairperson: Dr. Mitsumi Terada (National Cancer Center, Japan)

1225

Q&A Session 1
Dr. Mitsumi Terada
– Dr. Yolanda Augustin
Dr. Mastura Md Yusof

1240

Sponsored Lunch Talk (MyGenome Institute)
Networking

1340

Plenary Session 2
Targeting Treatment Resistance in Head and Neck Cancer through Unravelling Molecular Mechanisms
Professor Dr. Goh Boon Cher
(National University of Singapore, Singapore)
Chairperson: Professor Dr. Johnson Stanslas (Universiti Putra Malaysia)

1425

Invited Talk 4
Updates on Treatment of Gastroesophageal Cancers
Professor Dr. Ho Gwo Fuang
(Universiti of Malaya, Malaysia)
Chairperson: Dr. Mastura Md Yusof (Pantai Hospital Kuala Lumpur, Malaysia)

1445

Invited Talk 5
Targeting Lipid Metabolism in Non-Small Cell Lung Cancer Therapy
Dr. Azhar Bin Ali
(National University of Singapore, Singapore)
Chairperson: Dr. Jonathan Lim Chee Woei (Universiti Putra Malaysia)

1505

Q&A Session 2
Professor Dr. Ho Gwo Fuang
Dr. Azhar Bin Ali

1515

Sponsor Talk 2
Johnson & Johnson Sdn Bhd, Malaysia

1540

Afternoon Coffee/Tea Break
Poster Viewing & Judging Session 2

1610

Parallel Oral Sessions 1

Cancer Drug Discovery

Translational Cancer Medicine

1710

Invited Talk 6
Insights into Advanced Non-Small Cell Lung Cancer Patients with MET Alterations
Emeritus Professor Dr. Liam Chong Kin
(Universiti of Malaya, Malaysia)
Chairperson: Professor Dr. How Soon Hin (International Islamic University Malaysia)

1730

Invited Talk 7 (virtual)
Exploiting New Cancer Drug Targets that Drive Drug Resistant and Metastatic Disease
Professor Dr. Andrew D Westwell
(Cardiff University, United Kingdom)
Chairperson: Professor Dr. Gopal Natesan (MAHSA University)

1750

Q&A Session 3
Emeritus Prof Dr. Liam Chong Kin
Professor Dr. Andrew D Westwell

1800

Networking

1900

Gala Dinner



DAY 2: Conference (8th December 2022)

Time

Activities

0900

Plenary Session 3
The Identification of a Group of Self-Assembling, Trimetallic Cryptands with Multi-Kinase Inhibitor Activity Using a Phenotypic Approach to Drug Discovery
Professor Dr. Roger Phillips
(University of Huddersfield, United Kingdom)
Chairperson: Professor Dr. Johnson Stanslas (Universiti Putra Malaysia)

0945

Invited Talk 8
Emerging Immuno-cellular therapy in the Treatment of Diffuse large B-cell Lymphoma
Professor Dr. Bee Ping Chong
(Universiti of Malaya, Malaysia)
Chairperson: Associate Professor Dr. Bahariah Khalid (Universiti Putra Malaysia)

1005

Invited Talk 9
Cancer-Associated Fibroblasts as Potential Therapeutic Targets in Head and Neck Cancer
Professor Dr. Ian Paterson
(Universiti of Malaya, Malaysia)
Chairperson: Dr. Lee Sau Har (Taylor’s University)

1025

Q&A Session 4
Professor Dr. Bee Ping Chong
Professor Dr. Ian Paterson

1035

Morning Coffee/Tea Break
Poster Viewing & Judging Session 3

1105

Invited Talk 10
Development of Biomarkers in Clinical Trials
Dr. Magdalena B Wozniak
(Novartis Pharma Ltd, Ireland)
Chairperson: Dr. Foo Jhi Biau (Taylor’s University, Malaysia)

1125

Invited Talk 11
Immune-checkpoint-inhibitors for Biliary Tract Cancer in the Era of Precision Medicine
Associate Professor Dr. Wan Zamaniah Wan Ishak
(University of Malaya, Malaysia)
Chairperson: Professor Dr. Bee Ping Chong (University of Malaya, Malaysia)

1145

Q&A Session 5
Dr. Magdalena B Wozniak
– Associate Professor Dr. Wan Zamaniah Wan Ishak

1155

Parallel Oral Sessions 2

Cancer Drug Discovery

Translational Cancer Medicine

1255

Lunch
Networking

1355

Invited Talk 12
Tips to Prepare a Successful Grant Proposal
Professor Dr. Roger Phillips
(University of Huddersfield, United Kingdom)
Chairperson: Associate Professor Dr. Steven Lim Siong Meng (Universiti Teknologi MARA (UiTM), Malaysia)

1425

Forum 2
Publishing in a High Impact Journal
Moderator: Dr. Chua Eng Wee (Universiti Kebangsaan Malaysia)
Panelists:
Professor Dr. Johnson Stanslas (Universiti Putra Malaysia)
Professor Dr. Ian Paterson (University of Malaya, Malaysia)
Professor Dr. Goh Boon Cher (National University of Singapore, Singapore)

1515

Sponsor Talk 3
Accelerating Cancer Biology Research with Agilent’s Cell Biology Portfolio
Mr. David Chung Tze Yang
(Agilent Technologies (Malaysia) Sdn Bhd)

1540

Afternoon Coffee/Tea Break
Networking

1610

Plenary Session 4 (virtual)
Precision Medicine in Lymphoid Malignancies
Professor Dr. Richard Rosenquist Brandell
(Karolinski Institute, Sweden)
Chairperson: Dr. Chua Eng Wee (Universiti Kebangsaan Malaysia)

1655

Awards Presentation
Closing Remark

1730

Networking

* Disclaimer: All are subject to change